Wang, L., Wang, Q., Gao, M., Fu, L., Li, Y., Quan, H., & Lou, L. (2018). STAT3 activation confers trastuzumab‐emtansine (T‐DM1) resistance in HER2‐positive breast cancer. Cancer Sci.
Chicago-stil citatWang, Lei, Quanren Wang, Mingzhao Gao, Li Fu, Yun Li, Haitian Quan, och Liguang Lou. "STAT3 Activation Confers Trastuzumab‐emtansine (T‐DM1) Resistance in HER2‐positive Breast Cancer." Cancer Sci 2018.
MLA-referensWang, Lei, et al. "STAT3 Activation Confers Trastuzumab‐emtansine (T‐DM1) Resistance in HER2‐positive Breast Cancer." Cancer Sci 2018.
Varning: dessa hänvisningar är inte alltid fullständigt riktiga.